CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 359910-360332 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T46980","span":{"begin":0,"end":422},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"She was started on parenteral methylprednisolone and subsequently tapered to oral prednisone after 5 days.Concomitantly she was started on methotrexate as a steroid sparing agent.Most recent chest x-ray after 4 months of treatment reveals near complete resolution of the hilar lymphadenopathy.At 5 months her optic neuropathy and facial dysesthesia had resolved, and she was left with mild persistent VI nerve dysfunction."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T387","span":{"begin":0,"end":422},"obj":"Sentence"}],"text":"She was started on parenteral methylprednisolone and subsequently tapered to oral prednisone after 5 days.Concomitantly she was started on methotrexate as a steroid sparing agent.Most recent chest x-ray after 4 months of treatment reveals near complete resolution of the hilar lymphadenopathy.At 5 months her optic neuropathy and facial dysesthesia had resolved, and she was left with mild persistent VI nerve dysfunction."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3659","span":{"begin":4,"end":7},"obj":"Disease"},{"id":"T3660","span":{"begin":124,"end":127},"obj":"Disease"},{"id":"T3661","span":{"begin":309,"end":325},"obj":"Disease"},{"id":"T3662","span":{"begin":315,"end":325},"obj":"Disease"},{"id":"T3663","span":{"begin":371,"end":374},"obj":"Disease"}],"attributes":[{"id":"A3659","pred":"mondo_id","subj":"T3659","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A3660","pred":"mondo_id","subj":"T3660","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A3661","pred":"mondo_id","subj":"T3661","obj":"http://purl.obolibrary.org/obo/MONDO_0002135"},{"id":"A3662","pred":"mondo_id","subj":"T3662","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A3663","pred":"mondo_id","subj":"T3663","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"She was started on parenteral methylprednisolone and subsequently tapered to oral prednisone after 5 days.Concomitantly she was started on methotrexate as a steroid sparing agent.Most recent chest x-ray after 4 months of treatment reveals near complete resolution of the hilar lymphadenopathy.At 5 months her optic neuropathy and facial dysesthesia had resolved, and she was left with mild persistent VI nerve dysfunction."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1977","span":{"begin":309,"end":325},"obj":"Phenotype"},{"id":"T1978","span":{"begin":337,"end":348},"obj":"Phenotype"}],"attributes":[{"id":"A1977","pred":"hp_id","subj":"T1977","obj":"http://purl.obolibrary.org/obo/HP_0001138"},{"id":"A1978","pred":"hp_id","subj":"T1978","obj":"http://purl.obolibrary.org/obo/HP_0012534"}],"text":"She was started on parenteral methylprednisolone and subsequently tapered to oral prednisone after 5 days.Concomitantly she was started on methotrexate as a steroid sparing agent.Most recent chest x-ray after 4 months of treatment reveals near complete resolution of the hilar lymphadenopathy.At 5 months her optic neuropathy and facial dysesthesia had resolved, and she was left with mild persistent VI nerve dysfunction."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T837","span":{"begin":191,"end":196},"obj":"Body_part"},{"id":"T838","span":{"begin":404,"end":409},"obj":"Body_part"}],"attributes":[{"id":"A837","pred":"uberon_id","subj":"T837","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A838","pred":"uberon_id","subj":"T838","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"She was started on parenteral methylprednisolone and subsequently tapered to oral prednisone after 5 days.Concomitantly she was started on methotrexate as a steroid sparing agent.Most recent chest x-ray after 4 months of treatment reveals near complete resolution of the hilar lymphadenopathy.At 5 months her optic neuropathy and facial dysesthesia had resolved, and she was left with mild persistent VI nerve dysfunction."}